BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 45 found
  Current Search:  macular: 373, degeneration: 45     

HTML
100%
June 2009 Briefing - Ophthalmology
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for June 2009.

This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes...

Modern Medicine:  Jul 2 2009 4:44PM
Matching: macular degeneration
Find similar documents
HTML
100%
Canadian Bio Med Attacks World's Leading Cause of Blindness
NEW YORK, MONTREAL and SAN DIEGO, CA, June 30 /PRNewswire-FirstCall/ -- Canadian Bio Med Systems Inc., a subsidiary of ICBS Ltd., (OTCPK: ICBT), and Ocular Therapeutics Inc.

of San Diego California, announced the development of a new AMD...

Pharma Live:  Jul 2 2009 10:45AM
Matching: macular degeneration
Find similar documents
HTML
100%
Bilberry Helped Reverse Macular Degeneration
My wife had macular degeneration, and our ophthalmologist said it would just get worse.

We immediately started taking bilberry fruit capsules because I wanted to be pro-active.

A year later, we returned for her annual eye exam.

Peoples Pharmacy:  Jun 30 2009 12:33AM
Matching: macular degeneration
Find similar documents
HTML
100%
ThromboGenics' Microplasmin Phase III Program Progressing According To Schedule
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its lead product microplasmin, which is in...
Medical News Today:  Jun 26 2009 11:48AM
Matching: macular degeneration
Find similar documents
HTML
100%
Genetics and environment predict AMD
Like many diseases, causes for age-related macular degeneration (AMD) can be categorized as either 'nature' or 'nurture'.

Researchers think these factors, when used in the proper model, can be strong predictors of the disease.

AMD...

Scientist Live:  Jun 26 2009 5:09PM
Matching: macular degeneration
Find similar documents
HTML
100%
'Nature' And 'Nurture' Variables Early Predictors Of AMD
Like many diseases, causes for age-related macular degeneration (AMD) can be categorized as either 'nature' or 'nurture'.

Researchers think these factors, when used in the proper model, can be strong predictors of the disease.

AMD...

Medical News Today:  Jun 26 2009 11:45AM
Matching: macular degeneration
Find similar documents
HTML
100%
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
- Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development...
Pharma Live:  Jun 25 2009 11:49AM
Matching: macular degeneration
Find similar documents
HTML
100%
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
LEUVEN, Belgium, June 25 /PRNewswire-FirstCall/ -- - Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV , a biotechnology company focused on the...
KOTA Territory News:  Jun 25 2009 11:13AM
Matching: macular degeneration
Find similar documents
HTML
100%
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
- Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV , a biotechnology company focused on the discovery and development of innovative treatments...
KSLA:  Jun 25 2009 9:14AM
Matching: macular degeneration
Find similar documents
HTML
100%
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
LEUVEN, Belgium - Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery...
Genetic Engineering News:  Jun 25 2009 7:18AM
Matching: macular degeneration
Find similar documents
HTML
100%
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
- Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV , a biotechnology company focused on the discovery and development of innovative treatments...
KLFY:  Jun 25 2009 6:50AM
Matching: macular degeneration
Find similar documents
HTML
100%
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
Enter Symbols: Sponsored by: LEUVEN, Belgium, June 25 /PRNewswire-FirstCall/ -- - Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV , a...
TickerTech.com:  Jun 25 2009 6:38AM
Matching: macular degeneration
Find similar documents
HTML
100%
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
LEUVEN, Belgium, June 25 /PRNewswire-FirstCall/ -- - Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV Microplasmin's Phase III program is...
Montana's News Station:  Jun 25 2009 5:49AM
Matching: macular degeneration
Find similar documents
HTML
100%
'Nature' and 'nurture' variables early predictors of AMD
Rockville, MD Like many diseases, causes for age-related macular degeneration (AMD) can be categorized as either 'nature' or 'nurture'.

Researchers think these factors, when used in the proper model, can be strong predictors of the...

Genetic Engineering News:  Jun 25 2009 10:23PM
Matching: macular degeneration
Find similar documents
HTML
100%
Medical Study Establishes First-Ever Long-Term Benefits For Macular Degeneration Sufferers Using Macular Healt
According to the World Health Organization (WHO), age-related macular degeneration (AMD) ranks third as a cause of visual impairment.

It is the primary cause of visual impairment in industrial countries with a blindness prevalence of...

Medical News Today:  Jun 24 2009 10:37AM
Matching: macular degeneration
Find similar documents
HTML
100%
Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Healt
Latest Health News BIRMINGHAM, Ala., June 23 /PRNewswire/ -- According to the World Health Organization (WHO), age-related macular degeneration (AMD) ranks third as a cause of visual impairment.

It is the primary cause of visual...

KLFY:  Jun 23 2009 4:31PM
Matching: macular degeneration
Find similar documents
HTML
100%
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year
(Click the title below to leave the MDLinx Network and go to the Journal's Website) American Journal of Ophthalmology, 06/22/09 Print Save in My Library Free Abstract Lalwani GA et al.

- The PrONTO Study using an OCT-guided variable-dosing...

MDLinx:  Jun 23 2009 10:32AM
Matching: macular degeneration
Find similar documents
HTML
100%
Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a P
_ Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a P.
MDLinx:  Jun 23 2009 10:32AM
Matching: macular degeneration
Find similar documents
HTML
100%
Topical nepafenac efficacy is suggested by retrospective study
NSAID found effective whether used as monotherapy or in combination with a topical corticosteroid Ophthalmology Times Key Points A retrospective study analyzed outcomes in 18 patients who were treated for idiopathic or post-cataract surgery...
Ophthalmology Times:  Jun 20 2009 12:26AM
Matching: macular degeneration
Find similar documents
HTML
100%
Study describes long-term effects of PDT in wet AMD
Submit a Comment Photodynamic therapyis safe for long-term treatment of exudative age-related macular degeneration, but it is not definitive because it does not stop lesion growth.

In 262 patients treated with PDT for wet AMD who...

OSN Super Site:  Jun 19 2009 10:19PM
Matching: macular degeneration
Find similar documents
HTML
100%
Effectiveness of Magnifying Low Vision Aids in Patients with Age-Related Macular Degeneration
_ Effectiveness of Magnifying Low Vision Aids in Patients with Age-Related Macular Degeneration.
MDLinx:  Jun 17 2009 10:12PM
Matching: macular degeneration
Find similar documents
HTML
100%
Prospects for Nanomedicine in Treating Age-Related Macular Degeneration
_ Prospects for Nanomedicine in Treating Age-Related Macular Degeneration.
Medscape:  Jun 17 2009 7:15PM
Matching: macular degeneration
Find similar documents
HTML
100%
Major Breakthrough In Macular Degeneration
A team of researchers led by Dr.

Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.

The marker...

Medical News Today:  Jun 16 2009 8:54AM
Matching: macular degeneration
Find similar documents
HTML
100%
Biotechnology breakthrough against AMD
A team of researchers led by Dr.

Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.

The marker...

Scientist Live:  Jun 16 2009 5:54PM
Matching: macular degeneration
Find similar documents
HTML
100%
CCR3 Identified as Possible Target for Macular Degeneration Therapy
_ CCR3 Identified as Possible Target for Macular Degeneration Therapy.
Abstracts in Hematology and Oncology:  Jun 16 2009 6:31PM
Matching: macular degeneration
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.